Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice

Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice

Abstract Spinal muscular atrophy (SMA) is a single gene disorder affecting motor function in uterus. Amniotic fluid is an alternative source of stem cell to ameliorate SMA. Therefore, this study aims to examine the therapeutic potential of Human amniotic fluid stem cell (hAFSC) for SMA. Our SMA mode...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Steven W. Shaw, Shao-Yu Peng, Ching-Chung Liang, Tzu-Yi Lin, Po-Jen Cheng, T’sang-T’ang Hsieh, Hao-Yu Chuang, Paolo De Coppi, Anna L. David
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/836fd83ebb554beea76411f09fd719db
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/836fd83ebb554beea76411f09fd719db

Ejemplares similares